The absence of a BRAF V600E mutation has a sensitivity of 98.6% but a specificity of 66% for the identification of MLH1 mutation carriers in patients with a MSI/dMMR CRC with a loss of MLH1 [241]. Here, BRAF is linked to colorectal carcinoma.